Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
Spoerke, Jill M., Gendreau, Steven, Walter, Kimberly, Qiu, Jiaheng, Wilson, Timothy R., Savage, Heidi, Aimi, Junko, Derynck, Mika K., Chen, Meng, Chan, Iris T., Amler, Lukas C., Hampton, Garret M., JoVolume:
7
Language:
english
Journal:
Nature Communications
DOI:
10.1038/ncomms11579
Date:
May, 2016
File:
PDF, 1.02 MB
english, 2016